Peripheral nerve stimulation for restless legs syndrome
Non-invasive peripheral nerve stimulation with personalized parameter adjustment using surface EMG sensing effectively treats RLS and PLMD by addressing variability in patient responses, achieving a 6.64-point reduction in RLS severity and improved response rates.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- NOCTRIX HEALTH INC
- Filing Date
- 2020-10-02
- Publication Date
- 2026-05-25
AI Technical Summary
Existing electrical nerve stimulation therapies for conditions like Restless Legs Syndrome (RLS) and Periodic Leg Movement Disorder (PLMD) face variability in effectiveness due to individual patient responses, leading to challenges in establishing safe and reliable nerve activation, and current treatments often have significant side effects or require invasive medical devices.
A method involving non-invasive peripheral nerve stimulation (NPNS) using high-frequency pulsed electrical stimulation, coupled with surface EMG sensing to determine personalized stimulation parameters, including frequency and current levels, to effectively treat RLS and PLMD by identifying and adjusting to individual patient thresholds.
The method significantly reduces RLS symptoms by personalizing nerve stimulation, improving treatment efficacy and reducing side effects, as demonstrated by a 6.64-point reduction in RLS severity and increased response rate in clinical trials.
Smart Images

Figure 0007864348000002 
Figure 0007864348000003 
Figure 0007864348000004